April 2nd 2025
Epax has announced the launch of what they say is the first commercially available very long chain polyunsaturated fatty acid (VLC-PUFA), called Epax Evolve 05.
Omega-3 VITAL study results “better than expected” despite negative primary findings, GOED says
November 13th 2018Although researchers did not find a reduction in the primary endpoint of significantly reducing major CVD events, the study did reveal some positive, statistically significant benefits, the association says.
GOED targets health practitioners with new omega-3 educational campaign
October 2nd 2018The Global Organization for EPA and DHA Omega-3s is making a push to spread awareness of omega-3s among healthcare professionals, including nurse practitioners, physician’s assistants, and pharmacists, with the launch of its new Fats for Life website.
Interaction between omega-3 fatty acids, statins for heart health explored in review
October 1st 2018The review found that the combination of omega-3s and statins for heart health can sometimes be complementary, but can also be antagonistic. The authors note that further intervention studies are needed to explore the interaction.
REDUCE-IT omega-3 study results show efficacy of EPA-only drug for heart disease
September 25th 2018Amarin Corp., maker of Vascepa, a high-concentration EPA-only omega-3 drug for heart health, published the topline results from its large-scale Reduction of Cardiovascular Events with EPA Intervention Trial (REDUCE-IT).
Omega-3 Cochrane meta-analysis is highly flawed, researcher writes
August 30th 2018Bill Harris, PhD, omega-3 researcher and founder of OmegaQuant, says a recent Cochrane report is biased because it ignores a large body of evidence showing favorable effects of EPA and DHA on cardiovascular risk.
High-protein, low-carbohydrate diet with omega-3 lowers blood glucose in animal study
July 26th 2018In the study, mice that were fed a high-protein, high-omega-3, low-carbohydrate diet exhibited lower blood glucose levels, including in induced type 1 diabetes, hormone-induced hyperglycemia, and diet-induced metabolic syndrome.
Fatty Fish Intake Cognitive Benefits Mostly Neutral in Preschool Children, Study Suggests
July 16th 2018In their main analysis, researchers found no significant cognitive benefits in Norwegian preschool students fed a fatty fish lunch versus a non-fish meat lunch for 16 weeks; however, they detected slight benefits in a sub-analysis adjusted for dietary compliance.
Omega-3 Compound Reduces Inflammation in Cystic Fibrosis Patients in New Pilot Study
July 2nd 2018In the pilot study, MaxSimil increased omega-3 red blood cell levels, moderated the ratio of arachidonic acid (AA) to docosahexaenoic acid (DHA), and reduced key inflammatory biomarkers in subjects with cystic fibrosis.
GOED's Ellen Schutt Discusses Omega-3 Market Challenges, Opportunities
May 18th 2018Nutritional Outlook recently spoke with Ellen Schutt, GOED’s new executive director, about how, under her leadership, the organization plans to identify market opportunities to move the omega-3 category forward.